Citations

Showing 10 of 108104 citations.

Human outgrowth knee fibroblasts from patients undergoing total knee arthroplasty exhibit a unique gene expression profile and undergo myofibroblastogenesis upon TGFβ1 stimulation
Bayram, Banu , Thaler, Roman , Bettencourt, Jacob W. , Limberg, Afton K. , Sheehan, Kevin P., Owen, Aaron R. , Berry, Daniel J., Wijnen, André J. van , Dudakovic, Amel , Berry, Daniel J. , Sanchez-Sotelo, Joaquin, van Wijnen, Andre J , Abdel, Matthew P , Berry, Daniel J , Berry, Daniel J., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Abdel, Matthew P.

Mayo Clinic

Journal of Cellular Biochemistry | February 28, 2022 | Volume: 123 | Issue: 5 | Pages: 878-892

10.1002/jcb.30230 | PMID 35224764 Get It

AbstractArthrofibrosis is characterized by excessive extracellular matrix (ECM) deposition that results in restricted joint motion after total knee arthroplasties (TKAs). Currently, treatment options are limited. Therefore, an in vitro model of knee‐related myofibroblastogenesis is valuable to facilitate investigation of the arthrofibrotic process, diagnostic and therapeutic options. In this study, we obtained intraoperative posterior capsule (PC), quadriceps tendon (QT), and suprapatellar pouch (SP) tissues from the knees of four patients undergoing primary TKAs for osteoarthritis. From these tissues, we isolated primary cells by the outgrowth method and subsequently characterized these cells in the absence and presence of the pro‐myofibroblastic cytokine, transforming growth factor beta 1 (TGFβ1). Light microscopy of knee outgrowth cells revealed spindle‐shaped cells, and immunofluorescence (IF) analysis demonstrated staining for the fibroblast‐specific markers TE‐7 and vimentin (VIM). These knee outgrowth fibroblasts differentiated readily into myofibroblasts as reflected by enhanced α‐smooth muscle actin (ACTA2) mRNA and protein expression and increased mRNA expression of collagen type 1 (COL1A1) and type 3 (COL3A1) with collagenous matrix deposition in the presence of TGFβ1. Outgrowth knee fibroblasts were more sensitive to TGFβ1‐mediated myofibroblastogenesis than adipose‐derived mesenchymal stromal/stem cells (MSCs). While outgrowth knee fibroblasts isolated from three anatomical regions in four patients exhibited similar gene expression, these cells are distinct from other fibroblastic cell types (i.e., Dupuytren's fibroblasts) as revealed by RNA‐sequencing. In conclusion, our study provides an in vitro myofibroblastic model of outgrowth knee fibroblasts derived from patients undergoing primary TKA that can be utilized to study myofibroblastogenesis and assess therapeutic strategies for arthrofibrosis.
Brachial plexus lipomatosis with perineurial pseudoonion bulb formation: Result of a mosaic PIK3CA mutation in the para‐axial mesoderm state
Ebner, Blake A. , Eschbacher, Kathryn L. , Jack, Megan M. , Milosevic, Dragana , Spinner, Robert J. , Dragana, Milosevic, Giannini, Caterina

Mayo Clinic

Brain Pathology | February 28, 2022 | Volume: 32 | Issue: 4 | Pages: No page available

10.1111/bpa.13057 | PMID 35224812 Get It

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
Shir, Dror , Graff‐Radford, Jonathan, Hofrenning, Ekaterina I. , Lesnick, Timothy G. , Przybelski, Scott A. , Lowe, Val J. , Petersen, Ronald C. , Jack, Clifford R. , Vemuri, Prashanthi , Campbell, Michelle R. , Stricker, Nikki H. , Jack, Clifford R , Vemuri, Prashanthi , Shir, Dror , Graff‐Radford, Jonathan , Knopman, David S. , Algeciras‐Schimnich, Alicia , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | February 28, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12291 | PMID 35252538 Get It

Abstract Introduction : Plasma glial fibrillary acidic protein (GFAP) may be associated with amyloid burden, neurodegeneration, and stroke but its specificity for Alzheimer's disease (AD) in the general population is unclear. We examined associations of plasma GFAP with amyloid and tau positron emission tomography (PET), cortical thickness, white matter hyperintensities (WMH), and cerebral microbleeds (CMBs). Methods : The study included 200 individuals from the Mayo Clinic Study of Aging who underwent amyloid and tau PET and magnetic resonance imaging and had plasma GFAP concurrently assayed; multiple linear regression and hurdle model analyses were used to investigate associations controlling for age and sex. Results : GFAP was associated with amyloid and tau PET in multivariable models. After adjusting for amyloid, the association with tau PET was no longer significant. GFAP was associated with cortical thickness, WMH, and lobar CMBs only among those who were amyloid‐positive. Discussion : This cross‐sectional analysis demonstrates the utility of GFAP as a plasma biomarker for AD‐related pathologies.
Survey Study on the Experience, Practice Patterns, and Preferences of the Fellows of the Society of Radiologists in Ultrasound for Evaluation and Management of Gallbladder Polyps Detected With Ultrasound
Middleton, William D., Fung, Christopher, Dahiya, Nirvikar, Szpakowski, Jean-Luc, Corwin, Michael T., Fetzer, David T., Gabriel, Helena, Rodgers, Shuchi K., Tublin, Mitchell E., Walsh, Andrew J., Kamaya, Aya, Fetzer, David T. , Middleton, William D., Fung, Christopher, Dahiya, Nirvikar, Szpakowski, Jean-Luc, Corwin, Michael T., Gabriel, Helena, Rodgers, Shuchi K., TUBLIN, MITCHELL E. , Walsh, Andrew J., Kamaya, Aya

Mayo Clinic

Ultrasound Quarterly | February 28, 2022 | Volume: 38 | Issue: 2 | Pages: 96-102

10.1097/ruq.0000000000000597 | PMID 35221317 Get It

Abstract Gallbladder polyps (GPs) are a common incidental finding on ultrasound; however, important differences in recommended management exist among professional society guidelines. An electronic survey was sent to 189 fellows of the Society of Radiologists in Ultrasound. Main outcomes included preferences and current practice patterns for evaluation, management, and surveillance of GPs as well as personal lifetime experience with gallbladder sonography and GPs. A total of 64 subjects (34%) with experience in gallbladder sonography completed the study. The estimated combined total number of gallbladder scans seen by the responders was 3,071,880. None of fellows had ever seen a pedunculated GP <1 cm detected on ultrasound that was proven to be malignant at the time of detection or during subsequent follow-up. All of the fellows used size as a feature to stratify recommendations. The median size threshold currently used by Society of Radiologists in Ultrasound fellows for recommending ultrasound follow-up was 6 mm, and their preferred threshold was 7 mm. The median size threshold for recommending surgical consultation was 10 mm, and the preferred threshold was 10 mm. Wall thickening and shape were considered important factors by 76% and 67% of respondents, respectively. Society of Radiologists in Ultrasound fellows tend to provide recommendations most similar to the American College of Radiology and Canadian Association of Radiology guidelines for management of GPs. Many would prefer guidelines that result in fewer recommendations for follow-up and surgical consultation. Despite a substantial combined experience, this survey did not uncover any case of a small GP that was malignant.
Palliative Care: A Survey of Program Benchmarking for Productivity and Compensation
Mayer, Adam Michael, Dahlin, Constance , Seidenschmidt, Lauren, Dillon, Hannah , Brown, Ashlyn, Crawford, Thomas, Coyne, Patrick J. , Dillon, Hannah

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | February 28, 2022 | Volume: 39 | Issue: 11 | Pages: 1298-1303

10.1177/10499091221077878 | PMID 35220754 Get It

Background: Palliative Care (PC) encompasses an integrated health care philosophy of care for individuals with serious illnesses and their families. Referrals to palliative care often come from other healthcare clinicians who lack the time and skill required to address the needs of the patient and their caregivers. At its heart, palliative care is individualized to the values, beliefs, and goals of the patient. The process of eliciting values, beliefs, and goals takes time and expertise, and correspondingly, palliative care is labor intensive. To date, there has been no concentrated focus on how to accurately capture the productivity or work of palliative care clinicians. As a result, there is not a universally accepted method of measuring the effort which includes impact, activity, composition, and productivity of a palliative care program. Objective: This paper reviews results obtained during a telephone survey of similar hospital-based palliative care programs on how they measure productivity. Currently, based on the survey, there are two focused methods for benchmarking: work relative value units (wRVU) and consult volume. This paper highlights the variability of wRVUs and the challenge of using them to compare different PC programs. Design: The design was an open-ended question telephone survey. Using the characteristics of our hospital program, the team created a composite of descriptions to consider for comparison. Then, various hospital-based palliative care teams were selected based on publicly reported data through Vizient, a national benchmarking organization. Based on a literature review, an open-ended question survey was created. These questions explored program composition, clinician productivity and performance benchmarks. Data was collected manually and stored in a confidential file. Result: Ninety-four programs were queried that met the following composite: (1) participated in Vizient program and (2) self-reported a hospital-based, inpatient palliative program. Forty-one programs responded to the request to participate. Of these, 32 programs consisted of facilities who had hospitalists who provided palliative care, but there was not a dedicated palliative care team. Nine programs had a dedicated palliative care team with clinicians who only practiced palliative medicine. Inquiry to these programs revealed that within these nine programs—two methods of capturing clinician productivity were used—five sites used a wRVU metric and four sites used a consult volume metric. Conclusion: Preliminary findings support the complexity of benchmarking PC programs against peer institutions with a standard productivity model based on the variability in program composition.
Simulated Electroconvulsive Therapy
McManus, Kaitlin R., Lapid, Maria I., Forester, Brent P., Mueller, Martina, Hermida, Adriana P., Nykamp, Louis, Harper, David G., Seiner, Stephen J., Sanghani, Sohag, Patrick, Regan, Gentry, Melanie T., Kung, Simon, Leal, Janette C., Johnson, Emily K., Petrides, Georgios, Patrick, Regan , McManus, Kaitlin R. , Lapid, Maria I., Forester, Brent P., Mueller, Martina, Hermida, Adriana P., Nykamp, Louis, Harper, David G., Seiner, Stephen J., Sanghani, Sohag, Patrick, Regan, Gentry, Melanie T., Kung, Simon, Leal, Janette C., Johnson, Emily K., Petrides, Georgios

Mayo Clinic

The Journal of ECT | February 27, 2022 | Volume: 38 | Issue: 3 | Pages: 165-170

10.1097/yct.0000000000000832 | PMID 35220356 Get It

Objectives Agitation is the most common behavioral symptom of Alzheimer disease (AD) affecting approximately 40% to 60% of the AD population, yet there are no Food and Drug Administration–approved therapies for the myriad of behavioral or psychological symptoms of dementia. There is growing evidence from naturalistic studies that electroconvulsive therapy (ECT) is a safe and effective treatment for agitation in AD patients who are refractory to pharmacotherapy and behavioral interventions. Despite the existing evidence, ECT remains underused because of stigma, lack of education, and concerns regarding adverse cognitive effects. Randomized controlled clinical trials of ECT are an opportunity to provide high-quality evidence of ECT as a safe and efficacious treatment for agitation in the AD population. We describe the methods for the Electroconvulsive Therapy in Alzheimer's Dementia study, which uses a novel, simulated ECT (S-ECT) control group to conduct a single-blind efficacy study of ECT for the treatment of agitation and aggression in individuals with moderate to severe AD. Methods We discuss the rationale, study design, methodology, ethical and practical challenges, and management strategies in using an S-ECT group as the comparator arm in this randomized controlled trial of ECT in AD-related treatment refractory agitation and aggression. Conclusions Validation of the safety and efficacy of ECT in patients with advanced AD with refractory agitation and aggression is necessary. This can be accomplished through creative formulation of S-ECT groups that effectively maintain the blind while providing scientific integrity.
Mapping Research on miRNAs in Cancer: A Global Data Analysis and Bibliometric Profiling Analysis
Shaw, Peter , Lokhotiya, Kartik, Kumarasamy, Chellan , Krishnan, Sunil , Suresh, Deepa, Muthukaliannan, Gothandam Kodiveri , Baxi, Siddhartha , Mani, Ravishankar Ram, Sivanandy, Palanisamy , Chandramoorthy, Harish C. , Samiappan, Suja , Jayaraj, Rama , Ram, M. Ravishankar , Krishnan, Sunil , Muthukaliannan, Gothandam Kodiveri , Ram, M Ravishankar , Sivanandy, Palanisamy , Chandramoorthy, Harish C , Jayaraj, Rama , Shaw, Peter , Shetty, Sameep , Gupta, Madan M.

Mayo Clinic

Pathophysiology | February 27, 2022 | Volume: 29 | Issue: 1 | Pages: 66-80

10.3390/pathophysiology29010007 | PMID 35366290 Get It

miRNAs biomarkers are emerging as an essential part of clinical oncology. Their oncogenic and tumour suppressor properties playing a role in malignancy has generated interest in their potential for use in disease prognosis. While several studies on miRNA have been carried out across the globe, evaluating the clinical implications of miRNAs in cancer diagnosis and prognosis research has currently not been attempted. A study delineating the area of miRNA research, including the topics presently being focused on, the seminal papers in this field, and the direction of research interest, does not exist. This study aims to conduct a large-scale, global data analysis and bibliometric profiling analysis of studies to evaluate the research output of clinical implications of miRNAs in cancer diagnosis and prognosis listed in the SCOPUS database. A systematic search strategy was followed to identify and extract all relevant studies, subsequently analysed to generate a bibliometric map. SPSS software (version 27) was used to calculate bibliometric indicators or parameters for analysis, such as year and country of affiliation with leading authors, journals, and institutions. It is also used to analyse annual research outputs, including total citations and the number of times it has been cited with productive nations and H-index. The number of global research articles retrieved for miRNA-Cancer research over the study period 2003 to 2019 was 18,636. Between 2012 and 2019, the growth rate of global publications is six times (n = 15,959; 90.71 percent articles) that of 2003 to 2011. (2704; 9.29 per cent articles). China published the most publications in the field of miRNA in cancer (n = 7782; 41%), while the United States had the most citations (n = 327,538; 48%) during the time span. Of these journals, Oncotarget has the highest percentage of article publications. The journal Cancer Research had the most citations (n = 41,876), with 6.20 per cent (n = 41,876). This study revealed a wide variety of journals in which miRNA-Cancer research are published; these bibliometric parameters exhibit crucial clinical information on performance assessment of research productivity and quality of research output. Therefore, this study provides a helpful reference for clinical oncologists, cancer scientists, policy decision-makers and clinical data researchers.
Contributing Factors to Low Energy Availability in Female Athletes: A Narrative Review of Energy Availability, Training Demands, Nutrition Barriers, Body Image, and Disordered Eating
Jagim, Andrew R. , Fields, Jennifer B. , Magee, Meghan K., Jones, Margaret T. , Jones, Margaret T , Jagim, Andrew R , Kerksick, Chad M.

Mayo Clinic

Nutrients | February 27, 2022 | Volume: 14 | Issue: 5 | Pages: 986

10.3390/nu14050986 | PMID 35267961 Get It

Relative Energy Deficiency in sport is experiencing remarkable popularity of late, particularly among female athletes. This condition is underpinned by low energy availability, which is a byproduct of high energy expenditure, inadequate energy intake, or a combination of the two. Several contributing factors exist that may predispose an athlete to low energy availability, and therefore a holistic and comprehensive assessment may be required to identify the root causes. The focus of the current narrative review is to discuss the primary contributing factors as well as known risk factors for low energy availability among female athletes to help practitioners increase awareness on the topic and identify future areas of focus.
Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months
Zahrieh, David , Satele, Daniel , Smith, Elizabeth , Loprinzi, Charles L. , Le‐Rademacher, Jennifer , Le-Rademacher, Jennifer G , Loprinzi, Charles , Lavoie Smith, Ellen M

Mayo Clinic

Cancers | February 27, 2022 | Volume: 14 | Issue: 5 | Pages: 1212

10.3390/cancers14051212 | PMID 35267520 Get It

While oxaliplatin-induced peripheral neuropathy (OIPN) is more common and severe in patients who receive the previous standard, 6-month oxaliplatin-based treatment, we hypothesized that OIPN was still pervasive in patients who received shorter, 3-month-treatment regimens. Using six EORTC QLQ-CIPN20 questions that quantify numbness (N), tingling (T) and shooting/burning pain (P) in upper/lower distal extremities, our aim is to quantify patient-reported responses over 3 months (6 cycles) of oxaliplatin regarding symptom-specific timing, location and severity. For each question, patients were asked how each of the sensory symptoms had affected them during the preceding week, with 1 = “Not at all”, 2 = “A little”, 3 = “Quite a bit” and 4 = “Very much”. The proportional odds model for the cumulative log odds of response that allowed symptom-specific patient heterogeneity to be obtained was applied to a pooled dataset from the placebo arms of two multisite OIPN prevention trials and fit separately to the upper/lower distal extremities. For each symptom, we report the cycle-specific marginal probabilities for each response. In 141 patients, substantial patient heterogeneity in the likelihood, at a given cycle, of a more severe response for a symptom was present. Distinct patterns in the probabilities for each response over time for N and T were observed between the upper/lower distal extremities, while the probabilities of a response >1 for P was largely negligible in both locations. Despite the decrease in exposure to oxaliplatin from 6 to 3 months, OIPN was still pervasive with patients experiencing considerable N and T in the fingers (or hands) and toes (or feet).
One-Year Prospective Association of BMI with Later Cognitive Development in Preschoolers
Hansen, Carina , Smith, Latasha M. , Lynch, Brian , Miccoli, Antonela , Romanowicz, Magdalena , Toussaint, Loren , Smith, Latasha , Lynch, Brian A , Toussaint, Loren L , Hansen, Carina K

Mayo Clinic

Brain Sciences | February 27, 2022 | Volume: 12 | Issue: 3 | Pages: 320

10.3390/brainsci12030320 | PMID 35326277 Get It

This study examined the prospective relationships between preschoolers’ body mass index (BMI) and cognitive development. BMI, cognitive (i.e., Brigance), sex, and age data were collected from seven cohorts of children attending Head Start from 2012 to 2018. Children (N = 324) with two years of complete data were included. After controlling for the first year cognitive development scores, age, gender, and the cohort, the BMI was predictive of lower cognitive development scores in year two (B = −0.06, β = −0.14, t = −3.19, p = 0.002). Female sex (B = 2.69, β = 0.10, t = 2.30, p = 0.022) and older age (B = 0.02, β = 0.15, t = 3.20, p ≤ 0.001) were also shown to be statistically significant predictors of improved year two cognitive scores. The initial BMI scores were associated with poorer one year cognitive development scores in this sample of preschool children. Excessive body mass may contribute to numerous biological, psychological, and social factors that inhibit children with obesity from reaching their full cognitive potential, during a time in which brain development and cognitive skills development are at critical points of growth. Early childhood obesity interventions may have positive consequences for cognitive development, but additional prospective studies are needed to confirm these results.